Results to your Biomarker

Biomarker
Exposure to
Matrix
Analytical Technique
NNAL
NNK (Nicotine-derived nitrosamine ketone)
Urine
LC-MS/MS

Matching services

biomonitoring

Biomonitoring

Human biomonitoring (HBM) is the determination of pollutants or their metabolites in biological material (blood, urine, saliva, etc.). With the help of HBM, the exposure to environmental chemicals can be assessed to identify vulnerable populations or regional differences.
tobacco

Tobacco Harm Reduction

Tobacco harm reduction is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. Biomarkers specific for the exposure to tobacco and smoke are key endpoints for evaluating new emerging nicotine products with a potentially reduced risk.

Scientific Contribution

publication
January 2018

Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products

Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284
publication
December 2009

Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers

Biomarkers, Volume 14, doi: 10.3109/13547500903242883
publication
March 2009

Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine

Journal of Chromatography B, Volume 877, doi: 10.1016/j.jchromb.2009.03.009
publication
March 2022

Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine Products

Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020